Navigation Links
Chief Medical Officers in Biotechs Finally Have Their Own Conference

New York, New York (PRWEB) January 31, 2013

For the first time, Chief Medical Officers at biotechs will have their own conference thanks to the idea from Dr Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the organizer of the event says, “We are grateful to Dr Stoner’s idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs.”    

The Chief Medical Officer Summit takes place in Boston on May 6-7, 2013 and is dedicated to accomplishing two goals:

1. To bring together CMO executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital, working and meeting with investors and strategsing for appropriate exits.
2. To create a network of CMOs from small to mid size life science companies to share ideas, solutions and support.

Dr Steven Zelenkofske, CMO & SVP Clinical and Medical Affairs, Regado Biosciences and advisor to the program remarked, "I am excited about this conference and think it is very much needed."

Event Details: May 6-7, Boston, MA
The event organizers are offering a 10% discount with code CMOE and a pre-early bird rate before 3/1. Click here to register.

Program Overview and Agenda are available at
Questions, please email service(at)theconferenceforum(dot)org

Speaking Faculty:
Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH
Mark Corrigan, MD, President & CEO, Zalicus
Anthony Coyle, PhD, VP & CSO, Centers for Therapeutic Innovation, Pfizer
Daniel Curran, MD, VP, Corporate Development, Millennium, Takeda Oncology
Greg Fiore, MD, CMO, The Medicines Company
Ken Getz, MBA, Senior Research Fellow, Tufts
Sheila Gujrathi, MD, CMO, Receptos
M. Scott Harris, MD, CMO, Avaxia Biologics; Principal, Middleburg Consultants; and Clinical Professor of Medicine, Georgetown University School of Medicine
Eric Hedrick, MD, CMO, Epizyme
Karin Hehenberger, MD, PhD, Executive Vice President & CMO, Coronado Biosciences
Dennis Kim, MD, MBA, CMO, Zafgen
Chris Kiritsy, MBA, President & CEO, Arisaph
Lori Kunkel, MD, CMO, Pharmacyclics
Tyler Martin, MD, President, CMO & Director, Dynavax Technologies
Robert Pyke, MD, PhD, CMO, S1 Biopharma
Jim Roach, MD, CMO & Senior Vice President, Development, Momenta Pharmaceuticals
Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
Jeffrey Sherman, MD, FACP, CMO & Executive Vice President, Development, Manufacturing, and Regulatory Affairs, Horizon Pharma
Greg Simon, CEO, Poliwogg
Elizabeth Stoner, MD, Managing Director, MPM Capital
Mary Szela, MBA, Senior Vice President, Pharmaceutical Operations, Abbott Laboratories
Santosh Vetticaden, MD, PhD, CMO, ADVENTRX Pharmaceuticals
Nancy Wetherbee, MBA, ORBIT Director, Tufts Medical Center
Steven Zelenkofske, DO, FACC, CMO & Senior Vice President, Clinical and Medical Affairs, Regado Bioscience

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
2. Elsevier Welcomes New Editor-in-Chief for European Urology
3. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
4. Mobility and Big Data Analytics Provider NuWare Announces the Appointment of Rohit Shyam as Chief Strategy & Marketing Officer
5. Dr. Gil Ben-Menachem appointed Chief Executive Officer of OphthaliX Inc.
6. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
7. T1D Exchange Announces Appointment of Dana Ball as Chief Executive Officer
8. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
9. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
10. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
11. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
Post Your Comments:
(Date:6/27/2016)... ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. ... has been advised by its major shareholders, Clean Technology ... United States based venture capital ... shares of Biorem (on a fully diluted, as converted ... the disposition of their entire equity holdings in Biorem ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former ... of the University of North Carolina Kenan-Flagler Business School effective June ... UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes and ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):